Project Grant K23MH144673
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Boston Children's Hospital a $990,550 Project Grant under the Mental Health Research Grants program (CFDA 93.242), effective March 10, 2026, with completion targeted for February 29, 2028. This R61/R33 phased research grant funds the development and testing of a computer-based cognitive control and metacognition training intervention designed to reduce restricted and repetitive behaviors in school-aged children...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $175,017 to the University of Houston System on September 15, 2025, under the Mental Health Research Grants program (CFDA 93.242). The project, titled "Investigating Neural Predictors of Real-World Social Attention in Autism During Naturalistic Social Interactions," addresses a critical gap in autism research by developing and validating objective measures of social attention...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Washington University a Project Grant of $811,412 under the Mental Health Research Grants program (CFDA 93.242) beginning May 1, 2026 and concluding February 28, 2031. The award funds research to establish the specificity and scalability of motor imitation assessments as a biomarker for Autism Spectrum Disorder (ASD). The research combines innovative wearable high-density diffuse optical tomography (HD-DOT)...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant of $824,728 on March 25, 2026, under the Mental Health Research Grants program (CFDA 93.242) to characterize intracortical feedforward and feedback sensory processes in autism spectrum disorder (ASD). The research project, which extends through December 31, 2030, will employ advanced multimodal neuroimaging techniques—combining magnetoencephalography (MEG) with...
- Federal Grant Award Summary Emory University received a $196,990 K23 Career Development Award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective May 1, 2026 through April 30, 2030. This award supports the development of an independent investigator with expertise in implementation science focused on increasing the uptake and utilization of evidence-based autism services in pediatric primary care settings. The project...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Maryland, Baltimore a Project Grant totaling $762,566 under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026, with a completion date of December 31, 2030. This award funds comprehensive multi-omic and synaptic imaging research designed to advance understanding of cerebellar mechanisms underlying Autism Spectrum Disorders (ASDs). The project will generate...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $1,157,832 under the Mental Health Research Grants program (CFDA 93.242), effective August 26, 2025, with completion scheduled for May 31, 2030. The grant supports a five-year research initiative investigating the regulation and function of DNA methyltransferase 3A (DNMT3A)-mediated methylation in the brain, with particular focus on...
- Federal Grant Award Summary The National Institute of Mental Health awarded a $127,557 Project Grant to the University of California, Davis under the Mental Health Research Grants program (CFDA 93.242) for the period September 25, 2025 through September 24, 2027. This F31 Predoctoral Fellowship supports integrated multidisciplinary training in cellular and molecular neurobiology and immunology, with the primary deliverable being doctoral-level research investigation into brain aging processes in...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $863,276 to the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) on February 3, 2026, for a project grant titled "Resilience in Action: Assessing the Behavioral Target Mechanisms of the RIA Curriculum in Young Adults with Autism." The primary deliverable is a rigorous evaluation of the Resilience in Action (RIA) curriculum, a previously pilot-tested...
- Federal Grant Award Summary Children's Research Institute received a $654,005 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 1, 2026, with a completion date of March 31, 2031. This research initiative investigates the function of the paralaminar nucleus of the amygdala (PL) during the critical developmental transition from adolescence to early adulthood. The project will deliver scientific knowledge...
The National Institute of Mental Health (NIMH) awarded Baylor College of Medicine a Project Grant of $185,397 under the Mental Health Research Grants program (CFDA 93.242) on June 15, 2026, with completion scheduled for May 31, 2030. This mentored patient-oriented research career development award supports Dr. Evan Dalton's preparation as an independent clinician-investigator specializing in care delivery interventions for hospitalized children with autism spectrum disorder (ASD). The grant funds a comprehensive career development and research plan that combines advanced training in participant-engaged mixed methods, human-centered design, and clinical trial methodology with the conduct of a full-scale controlled trial implementing an ASD-specific care pathway for children with ASD and aggression at a pediatric medical hospital in Houston, Texas. The primary deliverables include Dr. Dalton's advanced professional development in intervention design and clinical trial execution, coupled with research products from a systems-level clinical trial intervention addressing behavioral and care coordination challenges unique to children with ASD in pediatric medical settings. This research addresses a significant clinical need, as ASD prevalence exceeds 3% in the United States and affected children frequently require hospitalization for co-occurring medical and psychiatric conditions that are difficult to manage within standard hospital protocols due to sensory sensitivities and behavioral characteristics inherent to the disorder.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $185.4k | 6/19/26 |